---
layout: page
title: Publications
---
<style>
p {
    text-align: justify;
}
</style>

<div class="container-lg">
    <div class="row">
        <div class="col-lg-12">
            <h1>Publications</h1>
            <hr/>
        </div>
    </div>
</div>

## 2025

1. Jingyu Zhu<sup>†</sup>, Suqi Cao, Tan Wang, Nannan Wang, Liu Yang, Xuanli Tang, Mengya Jiang, Qin Zhu, Hong Yu<sup>\*</sup>, **Dingfeng Wu**<sup>\*</sup>, Wan-Xin Peng<sup>\*</sup>. Guiqi Yishen granule alleviates obstructive nephropathy-induced renal fibrosis by targeting PI3K/AKT signaling pathway. **Journal of Ethnopharmacology**. **2026**;10, 354:120490. https://doi.org/10.1016/j.jep.2025.120490. PMID: 40865661.

1. Suqi Cao<sup>†</sup>, Lei Liu<sup>†</sup>, Liu Yang, Haomin Li, Ruixin Zhu, Gang Yu, Na Jiao<sup>\*</sup> and **Dingfeng Wu**<sup>\*</sup>. Assessing severe pneumonia risk in children via clinical prognostic model based on laboratory markers. **International Immunopharmacology** **2025**;151, 114317. https://doi.org/0.1016/j.intimp.2025.114317. PMID: 39983420.

1. Liu Yang<sup>†</sup>, Suqi Cao<sup>†</sup>, Lei Liu, Ruixin Zhu<sup>\*</sup> and **Dingfeng Wu**<sup>\*</sup>. cyclicpeptide: a Python package for cyclic peptide drug design. **Briefings in bioinformatics**. **2024**;26(1), bbae714. https://doi.org/10.1093/bib/bbae714. PMID: 39783893.

1. Genhui Zheng<sup>†</sup>, **Dingfeng Wu**<sup>†</sup>, Xiuxia Wei, Dongpo Xu, Tiantian Mao, Deyu Yan, Wenhao Han, Xiaoxiao Shang, Zikun Chen, Jingxuan Qiu, Kailin Tang, Zhiwei Cao<sup>\*</sup> and Tianyi Qiu<sup>\*</sup>.**Briefings in bioinformatics**. **2024**;26(1), bbae710. https://doi.org/10.1093/bib/bbae710.

## 2024


1. Lei Liu<sup>†</sup>, Suqi Cao<sup>†</sup>, Weili Lin<sup>†</sup>, Zhigang Gao, Liu Yang, Lixin Zhu, Bin Yang, Guoqing Zhang<sup>\*</sup>, Ruixin Zhu<sup>\*</sup> and **Dingfeng Wu**<sup>\*</sup>. miMatch: a microbial metabolic background matching tool for mitigating host confounding in metagenomics research. **Gut Microbes**. **2024**; 16(1), 2434029. https://doi.org/10.1080/19490976.2024.2434029. PMID: 39601293.

1. Lei Liu<sup>†</sup>, Liu Yang<sup>†</sup>, Suqi Cao, Zhigang Gao, Bin Yang, Guoqing Zhang<sup>\*</sup>, Ruixin Zhu<sup>\*</sup> and **Dingfeng Wu**<sup>\*</sup>. CyclicPepedia: a knowledge base of natural and synthetic cyclic peptides. **Briefings in bioinformatics**. **2024**; 25(3), bbae190. https://doi.org/10.1093/bib/bbae190. PMID: 38678388.

1. Xiaoyi Li<sup>†</sup>, **Dingfeng Wu**<sup>†</sup>, Qiuyu Li, Jinglan Gu, Wenxing Gao, Xinyue Zhu, Wenjing Yin, Ruixin Zhu<sup>\*</sup>, Lixin Zhu<sup>\*</sup>, and Na Jiao<sup>\*</sup>. Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer. **Physiol Genomics**. **2024** Feb 1;56(2):221-234. https://doi.org/10.1152/physiolgenomics.00103.2023. Epub 2023 Dec 11. PMID: 38073489.

1. Suqi Cao<sup>†</sup>, Zicheng Zhang<sup>†</sup>, Lei Liu, Yin Li, Wei Li, Yunling Li<sup>\*</sup> and **Dingfeng Wu**<sup>\*</sup>. Causal relationships between atopic dermatitis and psychiatric disorders: a bidirectional two-sample Mendelian randomization study. **BMC psychiatry**; **2024**, 24(1), 16. https://doi.org/10.1186/s12888-023-05478-1.

## 2023

1. Tingjun Xu<sup>†</sup>, Wenxing Gao<sup>†</sup>, Lixin Zhu<sup>\*</sup>, Wanning Chen, Chaoqun Niu, Wenjing Yin, Liangxiao Ma, Xinyue Zhu, Yunchao Ling, Sheng Gao, Lei Liu, Na Jiao, Weiming Chen, Guoqing Zhang<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, and **Dingfeng Wu**<sup>\*</sup>. NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease. **J. Chem. Inf. Model**. **2023**; https://pubs.acs.org/doi/10.1021/acs.jcim.3c00395.

1. Wenjun Gu<sup>†</sup>, LuChengChen Shu, WanNing Chen, Jinhua Wang, **Dingfeng Wu**<sup>\*</sup>, ZiSheng Ai<sup>\*</sup>, and Jiyu Li<sup>\*</sup>. Evaluation of Chinese Healthcare Organizations Innovative Performance in the Digital Health Era. **Front. Public Health**. **2023**; https://www.frontiersin.org/articles/10.3389/fpubh.2023.1141757.

1. Lei Liu<sup>†</sup>, Ruixin Zhu,and **Dingfeng Wu**<sup>\*</sup>. Misuse of reporter score in microbial enrichment analysis. **iMeta**. **2023**; e95. https://doi.org/10.1002/imt2.95.


## 2022

1. **Dingfeng Wu**<sup>†</sup>, Lei Liu<sup>†</sup>, Na Jiao<sup>†</sup>, Yida Zhang, Li Yang, Chuan Tian, Ping Lan, Lixin Zhu<sup>\*</sup>, Rohit Loomba<sup>\*</sup>, and Ruixin Zhu<sup>\*</sup>. Targeting Keystone Species Helps Restore the Dysbiosis of Butyrate-Producing Bacteria in Nonalcoholic Fatty Liver Disease. **iMeta**, **2022**; e61. https://doi.org/10.1002/imt2.61.

1.  Jing Zhong<sup>†</sup>, **Dingfeng Wu**<sup>†</sup>, Yuanyuan Zeng<sup>†</sup>, Gaosong Wu<sup>†</sup>, Ningning Zheng, Wenjin Huang, Yan Li, Xin Tao, Weize Zhu, Lili Sheng, Xiaoxu Shen, Weidong Zhang<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, and Houkai Li<sup>\*</sup>. The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease. **Microbiology spectrum**, **2022**; 10(6):e0246722. doi:10.1128/spectrum.02467-22.


## 2020

1. Sijing Cheng<sup>†</sup>, **Dingfeng Wu**<sup>†</sup>, Jie Li, Yifeng Zou, Yunle Wan, Lihan Shen, Lixin Zhu<sup>\*</sup>, Mang Shi, Linlin Hou, Tao Xu, Na Jiao, Yichen Li, Yibo Huang, Zhipeng Tang, Mingwei Xu, Shusong Jiang, Maokun Li<sup>\*</sup>, Guangjun Yan<sup>\*</sup>, Ping Lan<sup>\*</sup>, and Ruixin Zhu<sup>\*</sup>. Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study. **Respiratory Research**, **2020**; 21(1), 277. DOI: https://doi.org/10.1186/s12931-020-01492-zLu.

1. Fan<sup>†,\*</sup>, **Dingfeng Wu**<sup>†</sup>, Vadim Goremykin, Jing Xiao, YanbingXu, Sriram Garg, Chuanlun Zhang, William F. Martin<sup>\*</sup>, RuixinZhu<sup>\*</sup>. Phylogenetic analyses with systematic taxon sampling show that mitochondria branch within Alphaproteobacteria. **Nature Ecology & Evolution**, **2020**; 4(9), 1213–1219. DOI: https://doi.org/10.1038/s41559-020-1239-x.  

1. **Dingfeng Wu**<sup>†</sup>, WenxingGao<sup>†</sup>, Xiaoyi Li<sup>†</sup>, Chuan Tian, Na Jiao, Sa Fang, Jing Xiao, Zhifeng Xu, Lixin Zhu<sup>\*</sup>, Guoqing Zhang<sup>\*</sup> and Ruixin Zhu<sup>\*</sup>. Dr AFC: Drug Repositioning Through Anti-Fibrosis Characteristic. **Briefings in Bioinformatics**, **2020**; 22(3). DOI: https://doi.org/10.1093/bib/bbaa115.

1. Yunle Wan<sup>†</sup>, Jie Li<sup>†</sup>, Lihan Shen<sup>†</sup>,Yifeng Zou<sup>†</sup>, Linlin Hou<sup>†</sup>, Lixin Zhu<sup>†,\*</sup>, Howard S.Faden, Zhipeng Tang, Mang Shi, Na Jiao, Yichen Li, Sijing Cheng, Yibo Huang, **Dingfeng Wu**, ZhifengXu, Linnuo Pan, Jun Zhu, GuangjunYan<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, and Ping Lan<sup>\*</sup>. Enteric involvement in hospitalised patients with COVID-19 outside Wuhan. **The Lancet Gastroenterology & Hepatology**, **2020**; 5(6), 534–535. DOI: https://doi.org/10.1016/S2468-1253(20)30118-7.


## Before 2020

1. Tianyi Qiu<sup>†</sup>, Yiyan Yang<sup>†</sup>, JingxuanQiu, Yang Huang, Tianlei Xu, Han Xiao, **Dingfeng Wu**, QingchenZhang, Chen Zhou, Xiaoyan Zhang, KailinTang, Jianqing Xu<sup>\*</sup>, and ZhiweiCao<sup>\*</sup>. CE-BLAST makes it possible to compute antigenic similarity for newly emerging pathogens. **Nature communications**, **2018**; 9(1), 1772. DOI: https://doi.org/10.1038/s41467-018-04171-2.

1. Tianyi Qiu<sup>†</sup>, **Dingfeng Wu**<sup>†</sup>, JingxuanQiu, and Zhiwei Cao<sup>\*</sup>. Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on Proteochemometric modelling. **Journal of cheminformatics**, **2018**; 10(1), 21. DOI: https://doi.org/10.1186/s13321-018-0275-x.

1. Tianyi Qiu<sup>†</sup>, **Dingfeng Wu**<sup>†</sup>, LinLin Yang, Hao Ye, Qiming Wang, Zhiwei Cao<sup>\*</sup>, and Kailin Tang<sup>\*</sup>. Exploring the mechanism of flavonoids through systematic bioinformatics analysis. **Frontiers in pharmacology**, **2018**; 9:918. DOI: https://doi.org/10.3389/fphar.2018.00918.

1. Tianyi Qiu<sup>†</sup>, Jingxuan Qiu, Jun Feng, **Dingfeng Wu**, YiyanYang, Kailin Tang, ZhiweiCao, and Ruixin Zhu<sup>\*</sup>. The recent progress in proteochemometricmodelling: focusing on target descriptors, cross-term descriptors and application scope. **Briefings in bioinformatics**, **2016**. 18(1), 125–136. DOI: https://doi.org/10.1093/bib/bbw004.

1. Jingxuan Qiu<sup>†</sup>,Tianyi Qiu, Yiyan Yang, **Dingfeng Wu**, and Zhiwei Cao<sup>\*</sup>. Incorporating structure context of HA protein to improve antigenicity calculation for influenza virus A/H3N2. **Scientific reports**, **2016**; 6, 31156. DOI: https://doi.org/10.1038/srep31156.

1. Jun Gao<sup>†</sup>, QingchenZhang<sup>†</sup>, Min Liu, Lixin Zhu, **Dingfeng Wu**, Zhiwei Cao, and RuixinZhu<sup>\*</sup>. bSiteFinder, an improved protein-binding sites prediction server based on structural alignment: more accurate and less time-consuming. **Journal of cheminformatics**, **2016**; 8, 38. DOI: https://doi.org/10.1186/s13321-016-0149-z.

1. Lei Liu<sup>†</sup>, Maria Tsompana, Yong Wang, **Dingfeng Wu**, Lixin Zhu, and RuixinZhu<sup>\*</sup>. Connection map for compounds (CMC): a server for combinatorial drug toxicity and efficacy analysis. **Journal of chemical information and modeling**, **2016**; 56(9), 1615–1621. DOI: https://doi.org/10.1021/acs.jcim.6b00397.

1. Ruixin Zhu<sup>†</sup>, Susan S Baker, Cynthia A Moylan, Manal F Abdelmalek, Cynthia D Guy, Fausto Zamboni, **Dingfeng Wu**, Weili Lin, WenshengLiu, Robert D Baker, Sugantha Govindarajan,Zhiwei Cao, Patrizia Farci, Anna Mae Diehl, and Lixin Zhu<sup>\*</sup>. Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers. **The Journal of pathology**, **2016**; 238(4), 531–542. DOI: https://doi.org/10.1002/path.4650.

1. Yi Sun<sup>†</sup>, Zhen Sheng<sup>†</sup>, Chao Ma, Kailin Tang, RuixinZhu, Zhuanbin Wu, Ruling Shen, Jun Feng, **Dingfeng Wu**, DanyiHuang, Dandan Huang, Jian Fei<sup>\*</sup>, Qi Liu<sup>\*</sup>, and Zhiwei Cao<sup>\*</sup>. Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer. **Nature communications**, **2015**; 6, 8481. DOI: https://doi.org/10.1038/ncomms9481.

1. **Dingfeng Wu**<sup>†</sup>, Tianyi Qiu<sup>†</sup>, Qingchen Zhang, Hong Kang, Shaohua Yuan, Lixin Zhu<sup>\*</sup>, and Ruixin Zhu<sup>\*</sup>. Systematic toxicity mechanism analysis of proton pump inhibitors: an in silico study. **Chemical research in toxicology**, **2015**; 28(3), 419–430. DOI: https://doi.org/10.1021/tx5003782.

1. Tianyi Qiu<sup>†</sup>, Han Xiao, Qingchen Zhang, Jingxuan Qiu, Yiyan Yang, Dingfeng Wu, Zhiwei Cao<sup>\*</sup>, and Ruixin Zhu<sup>\*</sup>. Proteochemometric modeling of the antigen-antibody interaction: new fingerprints for antigen, antibody and epitope-paratope interaction. **PloS one**, **2015**; 10(4), e0122416. DOI: https://doi.org/10.1371/journal.pone.0122416.

1. Tao Qi<sup>†</sup>, Tianyi Qiu<sup>†</sup>, Qingchen Zhang, Kailin Tang, Yangyang Fan, Jingxuan Qiu, **Dingfeng Wu**, Wei Zhang, Yanan Chen, Jun Gao, Ruixin Zhu<sup>\*</sup>, and Zhiwei Cao<sup>\*</sup>. SEPPA 2.0--more refined server to predict spatial epitope considering species of immune host and subcellular localization of protein antigen. **Nucleic acids research**, **2014**; 42(Web Server issue), W59–W63. DOI: https://doi.org/10.1093/nar/gku395.

1. Jun Gao<sup>†</sup>, Qi Huang<sup>†</sup>, **Dingfeng Wu**, Qingchen Zhang, Yida Zhang, Tian Chen, Qi Liu, Ruixin Zhu, Zhiwei Cao<sup>\*</sup>, and Yuan He<sup>\*</sup>. Study on human GPCR-inhibitor interactions by proteochemometric modeling. **Gene**, **2013**; 518(1), 124–131. DOI: https://doi.org/10.1016/j.gene.2012.11.061.

1. **Dingfeng Wu**<sup>†</sup>, Qi Huang<sup>†</sup>, Yida Zhang, Qingchen Zhang, Qi Liu, Jun Gao, Zhiwei Cao<sup>\*</sup>, and RuixinZhu<sup>\*</sup>. Screening of selective histone deacetylase inhibitors by proteochemometricmodeling. **BMC bioinformatics**, **2012**; 13, 212. DOI: https://doi.org/10.1186/1471-2105-13-212.

